Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
30.58
+0.78 (2.62%)
Oct 31, 2025, 4:08 PM HKT

HKG:2591 Statistics

Total Valuation

HKG:2591 has a market cap or net worth of HKD 13.97 billion. The enterprise value is 13.23 billion.

Market Cap13.97B
Enterprise Value 13.23B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:2591 has 456.82 million shares outstanding.

Current Share Class 420.29M
Shares Outstanding 456.82M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 10.12%
Owned by Institutions (%) 46.72%
Float 246.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 225.85
PB Ratio 18.67
P/TBV Ratio 19.35
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -54.40
EV / Sales 213.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -69.19

Financial Position

The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.08.

Current Ratio 3.55
Quick Ratio 3.36
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF -0.33
Interest Coverage -552.12

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -33.66%
Revenue Per Employee 589,071
Profits Per Employee -2.32M
Employee Count 105
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 40.58
200-Day Moving Average n/a
Relative Strength Index (RSI) 26.98
Average Volume (20 Days) 384,791

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2591 had revenue of HKD 61.85 million and -243.14 million in losses. Loss per share was -0.58.

Revenue 61.85M
Gross Profit 55.33M
Operating Income -257.13M
Pretax Income -243.14M
Net Income -243.14M
EBITDA -245.39M
EBIT -257.13M
Loss Per Share -0.58
Full Income Statement

Balance Sheet

The company has 804.28 million in cash and 62.36 million in debt, giving a net cash position of 741.92 million or 1.62 per share.

Cash & Cash Equivalents 804.28M
Total Debt 62.36M
Net Cash 741.92M
Net Cash Per Share 1.62
Equity (Book Value) 748.11M
Book Value Per Share 1.78
Working Capital 674.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -185.65 million and capital expenditures -5.53 million, giving a free cash flow of -191.17 million.

Operating Cash Flow -185.65M
Capital Expenditures -5.53M
Free Cash Flow -191.17M
FCF Per Share -0.42
Full Cash Flow Statement

Margins

Gross Margin 89.45%
Operating Margin -415.71%
Pretax Margin -393.09%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:2591 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1.74%
FCF Yield -1.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2591 has an Altman Z-Score of -2.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.39
Piotroski F-Score 1